Novo Nordisk’s weight-loss drug Wegovy could soon have a new sales outlet in the U.S.

Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...
TipRanks on MSN

Hims & Hers Stock (HIMS) Soars on Potential Deal to Offer Novo Nordisk’s Wegovy

Shares of Hims & Hers Health ($HIMS) rallied on Tuesday after management said it’s in discussions with Novo Nordisk ($NVO) to ...
Fierce Healthcare

Hims & Hers in talks with Novo Nordisk to sell Wegovy injections, new obesity pill

Hims & Hers continues to sell compounded semaglutide, the active ingredient in Novo’s Wegovy and Ozempic drugs, and these ...

Hims & Hers Eyes Major Weight-Loss Breakthrough With Potential Novo Nordisk Wegovy Deal

Hims & Hers Health (NYSE:HIMS) said it is holding discussions with Novo Nordisk (NYSE:NVO) to make the Danish drugmaker's ...

Why Metsera stock’s 20% surge signals a fierce Pfizer-Novo Nordisk bidding war

Metsera stock bidding war intensifies as Novo and Pfizer race to secure next-gen obesity drug assets amid surging market ...

Hims & Hers gains as analysts welcome talks with Novo for Wegovy sales

Hims & Hers Health (HIMS) stock rises as the company renews talks with Novo Nordisk (NVO) to sell the pharma giant's obesity drug Wegovy. Read more here.

Novo Nordisk Launches Wegovy® in Hong Kong for Weight Management

Leading global healthcare company Novo Nordisk announces the launch of Wegovy® in Hong Kong, now available at private clinics ...

Pfizer Files Antitrust, Contract Claims in Bid to Block Novo Nordisk Weight Loss Drug Acquisition

Pfizer alleges Novo Nordisk is attempting to "catch and kill" Metsera, a company Pfizer was in the process of acquiring, in ...